
Hair loss treatments
Oral finasteride was first approved for the treatment of androgenetic alopecia (male pattern hair loss) in 1997. Clinical studies support the drug’s efficacy and tolerability, but there are side ef...

XYON Health Clinical Studies: SiloxysSystem™ Gel
What is SiloxysSystem™ Gel? At XYON, we've combined decades of pharmaceutical and clinical expertise to develop an exceptional vehicle to deliver clinically proven hair loss medications.

DHT (dihydrotestosterone) is the male sex steroid hormone responsible for male pattern hair loss. DHT levels are dictated by DHT production and metabolism, which are processes dictated by genetics.